vimarsana.com
Home
Live Updates
EMPOWER-Lung3: Cemiplimab Plus Chemotherapy in Advanced NSCL
EMPOWER-Lung3: Cemiplimab Plus Chemotherapy in Advanced NSCL
EMPOWER-Lung3: Cemiplimab Plus Chemotherapy in Advanced NSCLC
Edgardo Santos, MD, FACP, FCCP, analyzes the influence on clinical practice arising from the application of cemiplimab with chemotherapy in advanced non-small cell lung cancer (NSCLC) observed in the EMPOWER-Lung3 trial.
Related Keywords
,
Recent Advancements ,
Treatment Approaches ,
Non Small Cell Lung Cancer ,
Nsclc ,
Lung Cancer ,
Advanced Nsclc ,
Advanced Non Small Cell Lung Cancer ,
Empower Lung3 ,
Cemiplimab ,
Chemotherapy ,
Nsclc Treatment ,
Non Small Cell Lung Cancer Treatment ,